We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Vitamin A Balance Critical to Proper Mitochondrial Function

By LabMedica International staff writers
Posted on 21 Oct 2009
A recent paper has linked the metabolic effects of vitamin A excess or deficiency to the well-being of mitochondria, the cellular organelles responsible for energy production.

Vitamin A is a fat-soluble vitamin that mediates normal functioning of the mucus membranes of the eye and respiratory tract, and the formation of visual pigments in the eye. More...
It is also essential for normal tissue growth and differentiation. Vitamin A can be manufactured in the body from beta-carotene, found in a variety of foods, particularly green vegetables and carrots as well as being obtained as retinol from fish oils, meat, and milk. Vitamin A deficiency increases the risk of infection, especially of the respiratory, digestive, and urinogenital tracts, and causes a number eye disorders, including night blindness. Excessive intakes of vitamin A can lead to nausea, vomiting, anorexia, headaches, hairlessness, bone and joint pain, and bone fragility.

Investigators at the Sloan-Kettering Institute for Cancer Research (New York, NY, USA) sought to determine why both a deficiency and an excess of vitamin A caused damage to so many different organs of the body. To this end they worked with cell cultures from humans and mice that expressed mutations to various molecular pathways governing functioning of the mitochondria.

They reported in the October 7, 2009, online edition of the FASEB Journal that retinol was essential for the metabolic fitness of mitochondria. When cells were deprived of retinol, respiration and ATP synthesis declined to basal levels. Energy output recovered to significantly higher levels as soon as retinol was restored to physiological concentration, without the need for metabolic conversion to other retinoids. At the molecular level retinol was found to be an essential cofactor of the enzyme protein kinase C-delta (PKC-delta), without which this enzyme failed to be activated in mitochondria. The molecular complex of PKC-delta and retinol increased energy output by signaling the pyruvate dehydrogenase complex for enhanced flux of pyruvate into the Krebs cycle.

"Our work illuminates the value and potential harm of vitamin A use in cosmetic creams and nutritional supplements," said senior author Dr. Ulrich Hammerling, professor of immunology at the Sloan-Kettering Institute for Cancer Research. "Although vitamin A deficiency is not very common in our society, over-use of this vitamin could cause significant dysregulation of energy production impacting cell growth and cell death."

Related Links:

Sloan-Kettering Institute for Cancer Research




Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Procalcitonin Test
LIAISON B•R•A•H•M•S PCT II GEN
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.